Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Investigation|November 15, 2022
Targeted Interleukin-9 delivery in pulmonary hypertension: Comparison of immunocytokine formats and effector cell studyJudith Heiss, Katja Grün, Laura Tempel, et al.
Molecular Cancer Therapeutics|December 29, 2012
The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenograftsEzia Bello, Giulia Taraboletti, Gennaro Colella, et al.
Histochemistry and Cell Biology|November 15, 2011
Differential vascular expression and regulation of oncofetal tenascin-C and fibronectin variants in renal cell carcinoma (RCC): implications for an individualized angiogenesis-related targeted drug deliveryKerstin Galler, Kerstin Junker, Marcus Franz, et al.
Molecular Cancer Therapeutics|October 24, 2015
Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor ResponseMarta Cesca, Lavinia Morosi, Alexander Berndt, et al.
Clinical Hemorheology and Microcirculation|June 4, 2019
Cellular inflammation in pulmonary hypertension: Detailed analysis of lung and right ventricular tissue, circulating immune cells and effects of a dual endothelin receptor antagonistIlonka Rohm, Katja Grün, Linda Marleen Müller, et al.
International Journal of Molecular Sciences|August 1, 2017
Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary HypertensionChristian Jung, Katja Grün, Stefan Betge, et al.
Journal of Molecular Histology|May 6, 2014
De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejectionMarcus Franz, Monika Matusiak-Brückner, Petra Richter, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Cancer Research|March 7, 2012
Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenograftsMichele Moschetta, Francesca Pretto, Alexander Berndt, et al.
Oncogene|May 5, 2022
The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2Marzieh Ehsani, Sophie Bartsch, Seyed Mohammad Mahdi Rasa, et al.
Pageof 10